Sassicaia Capital Advisers »

Kala Pharmaceuticals shares owned by Sassicaia Capital Advisers

Quarter-by-quarter ownership of Kala Pharmaceuticals (KALA) shares owned by Sassicaia Capital Advisers from 13F filings

Historical chart of Sassicaia Capital Advisers investment in Kala Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kala Pharmaceuticals held by Sassicaia Capital Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kala Pharmaceuticals by Sassicaia Capital Advisers

Quarter filed Position value Share count Share price at filing
2024-06-30 $85k 12k 7.09

More positions owned by Sassicaia Capital Advisers

Invesco Qqq Tr Unit Ser 1 (QQQ)
NVIDIA Corporation (NVDA)
Vaneck Etf Trust Semiconductr Etf (SMH)
Super Micro Computer (SMCI)
Hubspot (HUBS)
Microsoft Corporation (MSFT)
Spdr Ser Tr S&p Regl Bkg (KRE)
Meta Platforms Cl A (META)
Viking Therapeutics (VKTX)
Uber Technologies (UBER)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Nano Nuclear Energy (NNE)
FedEx Corporation (FDX)
Penn National Gaming (PENN)

View all positions for Sassicaia Capital Advisers

Top funds holding Kala Pharmaceuticals

Baker Bros. Advisors
Sr One Capital Management
Millennium Management
Vanguard Group
Virtu Financial
BlackRock
Board of Trustees of The Leland Stanford Junior University
Geode Capital Management
Sassicaia Capital Advisers
Tower Research Capital
Covestor
Morgan Stanley
Banque Cantonale Vaudoise
Compagnie Lombard, Odier SCA
Citigroup

View all funds holding Kala Pharmaceuticals